Welcome to LookChem.com Sign In|Join Free

CAS

  • or
[S-(R,R)]-1-[1-oxo-2-(3,4,5-trimethoxyphenyl)butyl]-2-piperdinecarboxylic acid, also known as 1-[1-oxo-2-(3,4,5-trimethoxyphenyl)butyl]piperidine-2-carboxylic acid, is a piperidine derivative with pharmaceutical potential. It features a carboxylic acid group and a phenyl ring with three methoxy substituents, which may allow it to interact with biological targets related to pain and inflammation.

195202-09-6 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • (S)-1-((S)-2-(3,4,5-trimethoxyphenyl)butanoyl)piperidine-2-carboxylic acid

    Cas No: 195202-09-6

  • USD $ 1.9-2.9 / Gram

  • 100 Gram

  • 1000 Metric Ton/Month

  • Chemlyte Solutions
  • Contact Supplier
  • 195202-09-6 Structure
  • Basic information

    1. Product Name: [S-(R*,R*)]-1-[1-oxo-2-(3,4,5-trimethoxyphenyl)butyl]-2-piperdinecarboxylic acid
    2. Synonyms: [S-(R*,R*)]-1-[1-oxo-2-(3,4,5-trimethoxyphenyl)butyl]-2-piperdinecarboxylic acid;(2R)-1-(2-(3,4,5-trimethoxyphenyl)butanoyl)piperidine-2-carboxylic acid
    3. CAS NO:195202-09-6
    4. Molecular Formula:
    5. Molecular Weight: 365.426
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 195202-09-6.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: [S-(R*,R*)]-1-[1-oxo-2-(3,4,5-trimethoxyphenyl)butyl]-2-piperdinecarboxylic acid(CAS DataBase Reference)
    10. NIST Chemistry Reference: [S-(R*,R*)]-1-[1-oxo-2-(3,4,5-trimethoxyphenyl)butyl]-2-piperdinecarboxylic acid(195202-09-6)
    11. EPA Substance Registry System: [S-(R*,R*)]-1-[1-oxo-2-(3,4,5-trimethoxyphenyl)butyl]-2-piperdinecarboxylic acid(195202-09-6)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 195202-09-6(Hazardous Substances Data)

195202-09-6 Usage

Uses

Used in Pharmaceutical Applications:
[S-(R,R)]-1-[1-oxo-2-(3,4,5-trimethoxyphenyl)butyl]-2-piperdinecarboxylic acid is used as a potential therapeutic agent for its anti-inflammatory and analgesic properties. Its chemical structure suggests that it may interact with biological targets involved in pain and inflammation, making it a candidate for further research and development in the medical field.
Used in Research and Development:
In the field of pharmaceutical research, [S-(R,R)]-1-[1-oxo-2-(3,4,5-trimethoxyphenyl)butyl]-2-piperdinecarboxylic acid is used as a subject of study to understand its pharmacological properties and potential medical uses. Further research is necessary to fully comprehend its interactions with biological targets and its efficacy in treating specific conditions.

Check Digit Verification of cas no

The CAS Registry Mumber 195202-09-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,5,2,0 and 2 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 195202-09:
(8*1)+(7*9)+(6*5)+(5*2)+(4*0)+(3*2)+(2*0)+(1*9)=126
126 % 10 = 6
So 195202-09-6 is a valid CAS Registry Number.

195202-09-6Relevant articles and documents

PROTEIN-BINDING COMPOUNDS

-

Paragraph 0521; 0543-0545, (2020/05/19)

The technology relates in part to compounds that bind to proteins. In certain examples, the compounds can bind to proteins that bind to rapamycin. In some examples, the compounds can bind to cellular proteins, and/or variant forms of cellular proteins, th

MULTIMERIC PIPERIDINE DERIVATIVES

-

Page/Page column 137; 138, (2019/07/13)

The technology relates in part to compounds that bind to multimeric ligand binding regions, referred to herein as "multimeric compounds." In certain examples, the multimeric compounds provided herein bind to and multimerize polypeptides that bind to rimiducid, such as for example, chimeric polypeptides that comprise FKBP12 polypeptide variant regions. Multimeric compounds provided include those having a structure of Formula I. Where A, Z, Y, Z' and A' moieties are described herein.

Synthetic process of homodimer of FKBP ligand

-

, (2019/05/28)

The invention discloses a synthesis process of homodimer of FKBP ligand and belongs to an improved synthesis process of AP1903, wherein the homodimer of FKBP ligand refers to AP1903. According to theoptimized route of the synthesis process chooses, (S)-piperidine-2-methyl formate is connected to the compound Cpd9' as selected, an acid Cpd6' obtained after ester hydrolysis is easier to be purified by post-treatment purification, and precipitation or extraction treatment can be chosen by the post-treatment purification. Although the total reaction steps of the synthetic route in the prior literature are the same as the optimized route of the invention, the synthetic route in the prior literature belongs to the vertical route, and the post-treatment of the fifth, sixth and eighth steps requires column chromatography, thereby leading to a higher research and development cost. The optimized AP1903 synthetic route belongs to the parallel route, and the post-treatment is simpler and more advantageous for separation and purification, so that the cost of research and development is relatively low and the economic benefit is obviously superior to that of the synthetic route in the prior art.

An Inexpensive and Scalable Synthesis of Shld

J?rgensen, Frederik Pr?stholm,Bols, Mikael

, p. 6050 - 6055 (2018/05/24)

A synthesis of the important FKBP ligand Shld is reported. The synthesis avoids stoichiometric use of expensive and chiral reagents, maintains enantioselectivity and provides a high overall yield (39%). The main features in the method are enantioselective alkylation for preparation of the phenyl acetic acid moiety (building block A), catalytic enantioselective reduction for obtaining the chiral diaryl-1-propanol (building block C), and direct acylation of S-pipecolic tartrate rather than use of expensive Fmoc-pipecolic acid. The assembly of the building blocks A-C is reversed in comparison to previous synthesis, which also eliminates the need for protective groups.

METHODS AND COMPOSITIONS FOR THE SYNTHESIS OF MULTIMERIZING AGENTS

-

, (2012/08/08)

The invention features methods and compositions for the synthesis of multimerizing agents.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 195202-09-6